A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
about
Current use of biologicals for the treatment of spondyloarthropathies.Oral desensitisation in rheumatoid arthritis.Effects of a hydrosoluble bacterial extract from Escherichia coli (OM-89) on cytokine production by peripheral blood mononuclear cells from healthy subjects and patients with rheumatoid arthritis.The effect of OM-89 (Subreum) on the murine model of systemic lupus erythematosus MRL-lpr/lpr.
P2860
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@ast
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@en
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@nl
type
label
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@ast
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@en
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@nl
prefLabel
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@ast
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@en
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@nl
P2860
P356
P1476
A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
@en
P2093
Vischer TL
P2860
P304
P356
10.1136/ARD.47.7.582
P407
P577
1988-07-01T00:00:00Z